Skip to main content
Erschienen in: Seminars in Immunopathology 4/2015

01.07.2015 | Review

The myths we believed in familial Mediterranean fever: what have we learned in the past years?

verfasst von: Seza Ozen, Ezgi Deniz Batu

Erschienen in: Seminars in Immunopathology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever is the most common monogenic periodic fever syndrome over the world especially in the eastern Mediterranean. It presents with recurrent and self-limited inflammatory attacks of fever and polyserositis along with high acute-phase reactants. The disease is associated with mutations in the MEFV gene that encodes pyrin, a component of inflammasome, which leads to exaggerated inflammatory response through uncontrolled production of interleukin 1. With the identification of the gene associated with the disease, we believed that everything was solved and that this was an ordinary monogenic disease with autosomal recessive inheritance. However, through the breathtaking progress in the basic research field as well as the clinical care of these patients, we have understood that the picture for this monogenic disorder was more complicated than we had anticipated. In this review, we have discussed the myths we believed in familial Mediterranean fever and how they have evolved during the past years.
Literatur
2.
Zurück zum Zitat Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–31PubMed Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29–31PubMed
3.
Zurück zum Zitat Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Kone-Paut I, De Benedetti F, Neven B, Hofer M, Dolezalova P, Kummerle-Deschner J, Touitou I, Hentgen V, Simon A, Girschick H, Rose C, Wouters C, Vesely R, Arostegui J, Stojanov S, Ozgodan H, Martini A, Ruperto N, Gattorno M, Paediatric Rheumatology International Trials Organisation E, Eurofever P (2012) An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 71(7):1177–1182. doi:10.1136/annrheumdis-2011-200549 PubMedCrossRef Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Kone-Paut I, De Benedetti F, Neven B, Hofer M, Dolezalova P, Kummerle-Deschner J, Touitou I, Hentgen V, Simon A, Girschick H, Rose C, Wouters C, Vesely R, Arostegui J, Stojanov S, Ozgodan H, Martini A, Ruperto N, Gattorno M, Paediatric Rheumatology International Trials Organisation E, Eurofever P (2012) An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 71(7):1177–1182. doi:10.​1136/​annrheumdis-2011-200549 PubMedCrossRef
4.
Zurück zum Zitat Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMFSG (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84(1):1–11PubMedCrossRef Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMFSG (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84(1):1–11PubMedCrossRef
5.
Zurück zum Zitat Balow JE Jr, Shelton DA, Orsborn A, Mangelsdorf M, Aksentijevich I, Blake T, Sood R, Gardner D, Liu R, Pras E, Levy EN, Centola M, Deng Z, Zaks N, Wood G, Chen X, Richards N, Shohat M, Livneh A, Pras M, Doggett NA, Collins FS, Liu PP, Rotter JI, Kastner DL et al (1997) A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics 44(3):280–291PubMedCrossRef Balow JE Jr, Shelton DA, Orsborn A, Mangelsdorf M, Aksentijevich I, Blake T, Sood R, Gardner D, Liu R, Pras E, Levy EN, Centola M, Deng Z, Zaks N, Wood G, Chen X, Richards N, Shohat M, Livneh A, Pras M, Doggett NA, Collins FS, Liu PP, Rotter JI, Kastner DL et al (1997) A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics 44(3):280–291PubMedCrossRef
7.
Zurück zum Zitat Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, Barron KS, Holland SM, Kastner DL, Aksentijevich I (2009) Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 60(6):1851–1861. doi:10.1002/art.24569 PubMedCentralPubMedCrossRef Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, Barron KS, Holland SM, Kastner DL, Aksentijevich I (2009) Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 60(6):1851–1861. doi:10.​1002/​art.​24569 PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, De Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn ME, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I, European Molecular Genetics Quality N (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71(10):1599–1605. doi:10.1136/annrheumdis-2011-201271 PubMedCentralPubMedCrossRef Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, De Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn ME, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I, European Molecular Genetics Quality N (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71(10):1599–1605. doi:10.​1136/​annrheumdis-2011-201271 PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Cazeneuve C, Hovannesyan Z, Genevieve D, Hayrapetyan H, Papin S, Girodon-Boulandet E, Boissier B, Feingold J, Atayan K, Sarkisian T, Amselem S (2003) Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 48(8):2324–2331. doi:10.1002/art.11102 PubMedCrossRef Cazeneuve C, Hovannesyan Z, Genevieve D, Hayrapetyan H, Papin S, Girodon-Boulandet E, Boissier B, Feingold J, Atayan K, Sarkisian T, Amselem S (2003) Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 48(8):2324–2331. doi:10.​1002/​art.​11102 PubMedCrossRef
10.
Zurück zum Zitat Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P, Pras M, Livneh A (2003) Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 30(1):185–190PubMed Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P, Pras M, Livneh A (2003) Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 30(1):185–190PubMed
11.
Zurück zum Zitat Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E (2009) Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60(6):1862–1866. doi:10.1002/art.24570 PubMedCrossRef Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E (2009) Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 60(6):1862–1866. doi:10.​1002/​art.​24570 PubMedCrossRef
12.
Zurück zum Zitat Kalyoncu M, Acar BC, Cakar N, Bakkaloglu A, Ozturk S, Dereli E, Tunca M, Kasapcopur O, Yalcinkaya F, Ozen S (2006) Are carriers for MEFV mutations “healthy”? Clin Exp Rheumatol 24(5 Suppl 42):S120–122PubMed Kalyoncu M, Acar BC, Cakar N, Bakkaloglu A, Ozturk S, Dereli E, Tunca M, Kasapcopur O, Yalcinkaya F, Ozen S (2006) Are carriers for MEFV mutations “healthy”? Clin Exp Rheumatol 24(5 Suppl 42):S120–122PubMed
13.
Zurück zum Zitat Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soyturk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750. doi:10.1093/rheumatology/kei279 CrossRef Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soyturk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750. doi:10.​1093/​rheumatology/​kei279 CrossRef
14.
Zurück zum Zitat Federici S, Calcagno G, Finetti M, Gallizzi R, Meini A, Vitale A, Caroli F, Cattalini M, Caorsi R, Zulian F, Tommasini A, Insalaco A, Sormani MP, Baldi M, Ceccherini I, Martini A, Gattorno M (2012) Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. Ann Rheum Dis 71(12):1961–1965. doi:10.1136/annrheumdis-2011-200977 PubMedCrossRef Federici S, Calcagno G, Finetti M, Gallizzi R, Meini A, Vitale A, Caroli F, Cattalini M, Caorsi R, Zulian F, Tommasini A, Insalaco A, Sormani MP, Baldi M, Ceccherini I, Martini A, Gattorno M (2012) Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. Ann Rheum Dis 71(12):1961–1965. doi:10.​1136/​annrheumdis-2011-200977 PubMedCrossRef
15.
Zurück zum Zitat Omenetti A, Carta S, Delfino L, Martini A, Gattorno M, Rubartelli A (2014) Increased NLRP3-dependent interleukin 1beta secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann Rheum Dis 73(2):462–469. doi:10.1136/annrheumdis-2012-202774 PubMedCrossRef Omenetti A, Carta S, Delfino L, Martini A, Gattorno M, Rubartelli A (2014) Increased NLRP3-dependent interleukin 1beta secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann Rheum Dis 73(2):462–469. doi:10.​1136/​annrheumdis-2012-202774 PubMedCrossRef
16.
Zurück zum Zitat Migita K, Agematsu K, Masumoto J, Ida H, Honda S, Jiuchi Y, Izumi Y, Maeda Y, Uehara R, Nakamura Y, Koga T, Kawakami A, Nakashima M, Fujieda Y, Nonaka F, Eguchi K, Furukawa H, Nakamura T, Nakamura M, Yasunami M (2013) The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population. PLoS One 8(2):e55227. doi:10.1371/journal.pone.0055227 PubMedCentralPubMedCrossRef Migita K, Agematsu K, Masumoto J, Ida H, Honda S, Jiuchi Y, Izumi Y, Maeda Y, Uehara R, Nakamura Y, Koga T, Kawakami A, Nakashima M, Fujieda Y, Nonaka F, Eguchi K, Furukawa H, Nakamura T, Nakamura M, Yasunami M (2013) The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population. PLoS One 8(2):e55227. doi:10.​1371/​journal.​pone.​0055227 PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Niemi K, Teirila L, Lappalainen J, Rajamaki K, Baumann MH, Oorni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186(11):6119–6128. doi:10.4049/jimmunol.1002843 PubMedCrossRef Niemi K, Teirila L, Lappalainen J, Rajamaki K, Baumann MH, Oorni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186(11):6119–6128. doi:10.​4049/​jimmunol.​1002843 PubMedCrossRef
18.
Zurück zum Zitat Schwabe AD, Peters RS (1974) Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine 53(6):453–462PubMedCrossRef Schwabe AD, Peters RS (1974) Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine 53(6):453–462PubMedCrossRef
19.
Zurück zum Zitat Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalcinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnere D, Michelon C, Seguret F, Gershoni-Baruch R, International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean F (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56(5):1706–1712. doi:10.1002/art.22507 PubMedCrossRef Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalcinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnere D, Michelon C, Seguret F, Gershoni-Baruch R, International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean F (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56(5):1706–1712. doi:10.​1002/​art.​22507 PubMedCrossRef
20.
Zurück zum Zitat Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T (2009) Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 68(2):246–248. doi:10.1136/ard.2008.092031 PubMedCrossRef Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T (2009) Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 68(2):246–248. doi:10.​1136/​ard.​2008.​092031 PubMedCrossRef
21.
Zurück zum Zitat Ozen S, Demirkaya E, Amaryan G, Kone-Paut I, Polat A, Woo P, Uziel Y, Modesto C, Finetti M, Quartier P, Papadopoulou-Alataki E, Al-Mayouf SM, Fabio G, Gallizzi R, Cantarini L, Frenkel J, Nielsen S, Hofer M, Insalaco A, Acikel C, Ozdogan H, Martini A, Ruperto N, Gattorno M, Paediatric Rheumatology International Trials O, Eurofever P (2014) Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis 73(4):662–667. doi:10.1136/annrheumdis-2012-202708 PubMedCrossRef Ozen S, Demirkaya E, Amaryan G, Kone-Paut I, Polat A, Woo P, Uziel Y, Modesto C, Finetti M, Quartier P, Papadopoulou-Alataki E, Al-Mayouf SM, Fabio G, Gallizzi R, Cantarini L, Frenkel J, Nielsen S, Hofer M, Insalaco A, Acikel C, Ozdogan H, Martini A, Ruperto N, Gattorno M, Paediatric Rheumatology International Trials O, Eurofever P (2014) Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis 73(4):662–667. doi:10.​1136/​annrheumdis-2012-202708 PubMedCrossRef
22.
Zurück zum Zitat Xu H, Yang J, Gao W, Li L, Li P, Zhang L, Gong YN, Peng X, Xi JJ, Chen S, Wang F, Shao F (2014) Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome. Nature 513(7517):237–241. doi:10.1038/nature13449 PubMedCrossRef Xu H, Yang J, Gao W, Li L, Li P, Zhang L, Gong YN, Peng X, Xi JJ, Chen S, Wang F, Shao F (2014) Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome. Nature 513(7517):237–241. doi:10.​1038/​nature13449 PubMedCrossRef
23.
25.
Zurück zum Zitat Ozen S, Balci B, Ozkara S, Ozcan A, Yilmaz E, Besbas N, Ozguc M, Kastner DL, Bakkaloglu A (2002) Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: speculations remain? Clin Exp Rheumatol 20(4 Suppl 26):S57–58PubMed Ozen S, Balci B, Ozkara S, Ozcan A, Yilmaz E, Besbas N, Ozguc M, Kastner DL, Bakkaloglu A (2002) Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: speculations remain? Clin Exp Rheumatol 20(4 Suppl 26):S57–58PubMed
27.
Zurück zum Zitat Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grutter C, Grutter M, Tschopp J (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14(8):1457–1466. doi:10.1038/sj.cdd.4402142 PubMedCrossRef Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grutter C, Grutter M, Tschopp J (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14(8):1457–1466. doi:10.​1038/​sj.​cdd.​4402142 PubMedCrossRef
33.
Zurück zum Zitat Giancane GTHN, Wulffraat N, Vastert B, Barron K, Hentgen V, Tilmann K, Ozdogan H, Lopez JA, Brogan P, Cantarini L, Frenkel J, Galeotti C, Gattorno M, Grateau G, Hofer M, Kone-Paut I, Kuemmerle-Deschner J, Lachmann H, Simon A, Feldman B, Uziel Y, Ozen S (2014) Evidence based recommendations for genetic diagnosis of familial Mediterranean fever. Pediatr Rheumatol 12(Suppl 1):241CrossRef Giancane GTHN, Wulffraat N, Vastert B, Barron K, Hentgen V, Tilmann K, Ozdogan H, Lopez JA, Brogan P, Cantarini L, Frenkel J, Galeotti C, Gattorno M, Grateau G, Hofer M, Kone-Paut I, Kuemmerle-Deschner J, Lachmann H, Simon A, Feldman B, Uziel Y, Ozen S (2014) Evidence based recommendations for genetic diagnosis of familial Mediterranean fever. Pediatr Rheumatol 12(Suppl 1):241CrossRef
34.
Zurück zum Zitat Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Ozguc M (2001) Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9(7):553–555. doi:10.1038/sj.ejhg.5200674 PubMedCrossRef Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Ozguc M (2001) Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9(7):553–555. doi:10.​1038/​sj.​ejhg.​5200674 PubMedCrossRef
35.
Zurück zum Zitat Ozen S, Besbas N, Bakkaloglu A, Yilmaz E (2002) Pyrin Q148 mutation and familial Mediterranean fever. QJM 95(5):332–333PubMedCrossRef Ozen S, Besbas N, Bakkaloglu A, Yilmaz E (2002) Pyrin Q148 mutation and familial Mediterranean fever. QJM 95(5):332–333PubMedCrossRef
38.
Zurück zum Zitat Daniels M, Shohat T, Brenner-Ullman A, Shohat M (1995) Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 55(3):311–314. doi:10.1002/ajmg.1320550313 PubMedCrossRef Daniels M, Shohat T, Brenner-Ullman A, Shohat M (1995) Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 55(3):311–314. doi:10.​1002/​ajmg.​1320550313 PubMedCrossRef
39.
Zurück zum Zitat Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25(12):2445–2449PubMed Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25(12):2445–2449PubMed
40.
Zurück zum Zitat Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda SI (2014) Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther 16(5):439. doi:10.1186/s13075-014-0439-7 PubMedCentralPubMedCrossRef Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda SI (2014) Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther 16(5):439. doi:10.​1186/​s13075-014-0439-7 PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, Konice M, Gul A (2005) A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int 25(6):442–446. doi:10.1007/s00296-004-0471-z PubMedCrossRef Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, Konice M, Gul A (2005) A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int 25(6):442–446. doi:10.​1007/​s00296-004-0471-z PubMedCrossRef
43.
Zurück zum Zitat Kasifoglu T, Calisir C, Cansu DU, Korkmaz C (2009) The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol 28(1):41–46. doi:10.1007/s10067-008-0980-3 PubMedCrossRef Kasifoglu T, Calisir C, Cansu DU, Korkmaz C (2009) The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol 28(1):41–46. doi:10.​1007/​s10067-008-0980-3 PubMedCrossRef
44.
Zurück zum Zitat Langevitz P, Livneh A, Zemer D, Shemer J, Pras M (1997) Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 27(2):67–72PubMedCrossRef Langevitz P, Livneh A, Zemer D, Shemer J, Pras M (1997) Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 27(2):67–72PubMedCrossRef
45.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26(3):612–627PubMedCrossRef Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, Pras M (1996) The changing face of familial Mediterranean fever. Semin Arthritis Rheum 26(3):612–627PubMedCrossRef
46.
Zurück zum Zitat Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Caliskan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24(2):323–327PubMed Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Caliskan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24(2):323–327PubMed
47.
Zurück zum Zitat Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30(4):281–287. doi:10.1053/sarh.2001.19958 PubMedCrossRef Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkmen A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30(4):281–287. doi:10.​1053/​sarh.​2001.​19958 PubMedCrossRef
48.
Zurück zum Zitat Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, Pras M, Livneh A (2001) Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 102(3):272–276PubMedCrossRef Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, Pras M, Livneh A (2001) Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 102(3):272–276PubMedCrossRef
49.
Zurück zum Zitat Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30(9):2014–2018PubMed Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30(9):2014–2018PubMed
52.
53.
54.
Zurück zum Zitat Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, Bassoy Y, Yilmaz E (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21(4):509–514PubMed Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, Bassoy Y, Yilmaz E (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21(4):509–514PubMed
55.
Zurück zum Zitat Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, Ben-Chetrit E (2011) Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 29(4 Suppl 67):S77–86PubMed Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, Ben-Chetrit E (2011) Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 29(4 Suppl 67):S77–86PubMed
58.
59.
Zurück zum Zitat Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 157(8):533–541. doi:10.7326/0003-4819-157-8-201210160-00003 PubMedCrossRef Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 157(8):533–541. doi:10.​7326/​0003-4819-157-8-201210160-00003 PubMedCrossRef
60.
Zurück zum Zitat Brik R, Butbul-Aviel Y, Lubin S, Ben Dayan E, Rachmilewitz-Minei T, Tseng L, Hashkes PJ (2014) Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6 month open-label, single-arm pilot study. Arthritis Rheum 66(11):3241–3243. doi:10.1002/art.38777 CrossRef Brik R, Butbul-Aviel Y, Lubin S, Ben Dayan E, Rachmilewitz-Minei T, Tseng L, Hashkes PJ (2014) Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6 month open-label, single-arm pilot study. Arthritis Rheum 66(11):3241–3243. doi:10.​1002/​art.​38777 CrossRef
61.
Zurück zum Zitat Piram M, Frenkel J, Gattorno M, Ozen S, Lachmann HJ, Goldbach-Mansky R, Hentgen V, Neven B, Stojanovic KS, Simon A, Kuemmerle-Deschner J, Hoffman H, Stojanov S, Duquesne A, Pillet P, Martini A, Pouchot J, Kone-Paut I, Eurofever, networks E (2011) A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (auto-inflammatory diseases activity index) consensus conference. Ann Rheum Dis 70(2):309–314. doi:10.1136/ard.2010.132613 PubMedCentralPubMedCrossRef Piram M, Frenkel J, Gattorno M, Ozen S, Lachmann HJ, Goldbach-Mansky R, Hentgen V, Neven B, Stojanovic KS, Simon A, Kuemmerle-Deschner J, Hoffman H, Stojanov S, Duquesne A, Pillet P, Martini A, Pouchot J, Kone-Paut I, Eurofever, networks E (2011) A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (auto-inflammatory diseases activity index) consensus conference. Ann Rheum Dis 70(2):309–314. doi:10.​1136/​ard.​2010.​132613 PubMedCentralPubMedCrossRef
62.
Zurück zum Zitat Piram M, Kone-Paut I, Lachmann HJ, Frenkel J, Ozen S, Kuemmerle-Deschner J, Stojanov S, Simon A, Finetti M, Sormani MP, Martini A, Gattorno M, Ruperto N, on the behalf of Eurofever E, the Paediatric Rheumatology International Trials Organisation n (2013) Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-203666 PubMedCentralPubMed Piram M, Kone-Paut I, Lachmann HJ, Frenkel J, Ozen S, Kuemmerle-Deschner J, Stojanov S, Simon A, Finetti M, Sormani MP, Martini A, Gattorno M, Ruperto N, on the behalf of Eurofever E, the Paediatric Rheumatology International Trials Organisation n (2013) Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. doi:10.​1136/​annrheumdis-2013-203666 PubMedCentralPubMed
63.
Zurück zum Zitat Ozen S, Demirkaya E, Duzova A, Erdogan O, Erken E, Gul A, Kasapcopur O, Kasifoglu T, Kisacik B, Ozdogan H, Tunca M, Acikel C, Vasculitis FMFA, Orphan disease Research in pediatric r, Turkish FMFsg (2014) FMF50: a score for assessing outcome in familial Mediterranean fever. Ann Rheum Dis 73(5):897–901. doi:10.1136/annrheumdis-2013-204719 PubMedCrossRef Ozen S, Demirkaya E, Duzova A, Erdogan O, Erken E, Gul A, Kasapcopur O, Kasifoglu T, Kisacik B, Ozdogan H, Tunca M, Acikel C, Vasculitis FMFA, Orphan disease Research in pediatric r, Turkish FMFsg (2014) FMF50: a score for assessing outcome in familial Mediterranean fever. Ann Rheum Dis 73(5):897–901. doi:10.​1136/​annrheumdis-2013-204719 PubMedCrossRef
Metadaten
Titel
The myths we believed in familial Mediterranean fever: what have we learned in the past years?
verfasst von
Seza Ozen
Ezgi Deniz Batu
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Seminars in Immunopathology / Ausgabe 4/2015
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-015-0484-6

Weitere Artikel der Ausgabe 4/2015

Seminars in Immunopathology 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.